Want to see CHRN full AI Analyst Report?
CHRN Stock Chart & Stats
$10.15
-$0.08(-9.64%)
At close: 4:00 PM EST
$10.15
-$0.08(-9.64%)
Day’s Range― - ―
52-Week Range$2.73 - $24.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)398.58K
Market Cap
$3.18B
Enterprise Value$28.59M
Total Cash (Recent Filing)$3.99M
Total Debt (Recent Filing)$4.32M
Price to Earnings (P/E)―
Beta1.56
Next Earnings
Aug 03, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.39
Shares Outstanding143,093,380
10 Day Avg. Volume392,348
30 Day Avg. Volume398,579
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.32
Price to Sales (P/S)1.64
P/FCF Ratio-1.75
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue2.47
Enterprise Value/Gross Profit4.68
Enterprise Value/Ebitda-2.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.1
Revenue Forecast (FY)$19.38M
Bulls Say, Bears Say
Bulls Say
Financial ResultsReported revenues above consensus and a smaller-than-expected net loss per share point to improving financial performance and could boost investor confidence.
M&AProposed merger with Applied Digital Cloud could provide Ekso Bionics with additional capital and cloud resources to stabilize operations and accelerate product development.
Revenue MomentumSequential recovery in sales and improving gross margins suggest that earlier order delays were idiosyncratic and may support renewed revenue momentum.
Bears Say
Asset Sale RiskIntent to pursue sale or divestiture of the legacy MedTech business could reduce recurring medical revenues and introduce execution risk during any transaction process.
Corporate UncertaintyAnnounced strategic review and potential transactions create uncertainty about future direction and could weigh on the stock until strategic outcomes are clarified.
Strategy ChangeMove away from commercializing exoskeletons toward other priorities undermines clarity on the company's core market strategy and may concern shareholders focused on the original technology opportunity.
ChronoScale News
CHRN FAQ
What was Chronoscale Corporation’s price range in the past 12 months?
Chronoscale Corporation lowest stock price was $2.73 and its highest was $24.00 in the past 12 months.
What is Chronoscale Corporation’s market cap?
Chronoscale Corporation’s market cap is $3.18B.
When is Chronoscale Corporation’s upcoming earnings report date?
Chronoscale Corporation’s upcoming earnings report date is Aug 03, 2026 which is in 34 days.
How were Chronoscale Corporation’s earnings last quarter?
Currently, no data Available
Is Chronoscale Corporation overvalued?
According to Wall Street analysts Chronoscale Corporation’s price is currently Overvalued.
Does Chronoscale Corporation pay dividends?
Chronoscale Corporation does not currently pay dividends.
What is Chronoscale Corporation’s EPS estimate?
Chronoscale Corporation’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Chronoscale Corporation have?
Chronoscale Corporation has 143,093,380 shares outstanding.
What happened to Chronoscale Corporation’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Chronoscale Corporation?
Currently, no hedge funds are holding shares in CHRN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ChronoScale Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Neutral
CHRN Sentiment 50%
Sector Average ―
Sector Average ―
Crowd Wisdom
Very Positive
Last 7 Days ▼ 3.1%
Last 30 Days ▲ 36.3%
Last 30 Days ▲ 36.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
582.38%
12-Months-Change
Fundamentals
Return on Equity
-177.40%
Trailing 12-Months
Asset Growth
-27.98%
Trailing 12-Months
Company Description
Chronoscale Corporation
Ekso Bionics Holdings, Inc., which began operations on January 30, 2012, and is headquartered in San Rafael, California, specializes in developing, refining, and marketing advanced exoskeleton technology. These innovative systems are currently applied in both the medical and industrial fields.
Technical Analysis
Ownership Overview
1.20% Insiders
0.02% Mutual Funds
<0.01% Other Institutional Investors
98.54% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---